NIH and partners to launch HIV vaccine efficacy trial in the Americas and Europe
The NIH and partners announced plans to conduct a Phase 3 HIV vaccine efficacy trial at multiple clinical research sites in North America, South America and Europe. The trial will assess an investigational vaccine regimen designed to induce immune responses against a variety of global HIV strains. July 15, 2019